Omission of Surgical Axillary Staging Noninferior To Sentinel Lymph Node Biopsy in Patients with cN0, T1 or T2 Invasive Breast Cancer
Findings from the INSEMA study
Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
Make sure you check these pages frequently, or sign up to our newsletter! To sign up for ESMO newsletters, create a myESMO account here and select the newsletters you’d like to receive.
Findings from the INSEMA study
Findings from the COG AALL1731 study
Evidence for efficacy is based on the results from the eNRGy study
New indication concerns a combination of nivolumab and ipilimumab for first-line treatment of patients with dMMR/MSI-H unresectable or metastatic colorectal cancer
Findings from the COMET study
Findings from the AQUILA study
New indication concerns treatment of adult patients with locally advanced, unresectable NSCLC whose tumours have EGFR exon 19 deletions or exon 21 (L858R) substitution mutations
Findings from the EMBER-3 study
Evidence for efficacy is based on the results from the HERIZON-BTC-01 study
Clinicopathologic, genomic, immunophenotypic, transcriptional features, and treatment outcomes
Findings from the IDENTIFY study
Findings from the FELIX study
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.